ISSN 0303-5212
 
2025, Vol: 50, Issue: 4
50 / 4Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Author_Certificate
Bank Reciept

Original Research 
RMJ. 2025; 50(4): 867-870


Dosimetric comparison of IMRT versus 3D-CRT for Stage T4 esophageal cancer

Ahmad Atta Qurashi, Muhammad Arshad Javid, Saeed Ahmad Buzdar, Attique Anwar Khan, Muhammad Shazad Shifa.


Abstract
Objective: To assess and compare the dosimetric outcomes of intensity-modulated radiation therapy (IMRT) and 3D conformal radiation therapy (3D-CRT) in treating stage T4 esophageal cancer (EC), with a focus on sparing organs at risk (OARs).
Methodology: Data of esophageal cancer (EC) patients (n=20, mean age=54, S.D±7 ) were taken from cancer center during 2024. Treatment plans of 3D-CRT and IMRT were evaluated using ECLIPSE software. Statistically, paired samples t-test was performed using Origin-Pro software to compare the means of dosimetric indices of IMRT versus 3D-CRT.
Results: IMRT provided a significant protection for OARs, decreasing the maximal dose 8.17% (p=0.01) and the mean dose 19.98% to the spinal cord. Lung doses also decreased significantly in D1% of 3.13% (p=0.09), D5% of 20.94% (p=0.07), and D95% of 32.2% (p=0.01). Furthermore, IMRT treatment plans of V-20% and V-30% comparison reduced 7.95% and 28.01% dose to lung volumes.
Conclusion: IMRT demonstrated statistically superior target dose delivery compared to 3D-CRT in all critical dosimetric outcomes including conformity, homogeneity, and uniformity indices for stage T4 esophageal cancer, while maintaining effective normal tissue protection for the spinal cord and lungs

Key words: Esophageal cancer( EC), dose calculation, IMRT, 3D-CRT.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Ahmad Atta Qurashi
Articles by Muhammad Arshad Javid
Articles by Saeed Ahmad Buzdar
Articles by Attique Anwar Khan
Articles by Muhammad Shazad Shifa
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Qurashi AA, Javid MA, Buzdar SA, Khan AA, Shifa MS. Dosimetric comparison of IMRT versus 3D-CRT for Stage T4 esophageal cancer. RMJ. 2025; 50(4): 867-870.

Web Style

Qurashi AA, Javid MA, Buzdar SA, Khan AA, Shifa MS. Dosimetric comparison of IMRT versus 3D-CRT for Stage T4 esophageal cancer. https://www.rmj.org.pk/?mno=262710 [Access: October 29, 2025].

AMA (American Medical Association) Style

Qurashi AA, Javid MA, Buzdar SA, Khan AA, Shifa MS. Dosimetric comparison of IMRT versus 3D-CRT for Stage T4 esophageal cancer. RMJ. 2025; 50(4): 867-870.


Vancouver/ICMJE Style

Qurashi AA, Javid MA, Buzdar SA, Khan AA, Shifa MS. Dosimetric comparison of IMRT versus 3D-CRT for Stage T4 esophageal cancer. RMJ. (2025), [cited October 29, 2025]; 50(4): 867-870.


Harvard Style

Qurashi, A. A., Javid, . M. A., Buzdar, . S. A., Khan, . A. A. & Shifa, . M. S. (2025) Dosimetric comparison of IMRT versus 3D-CRT for Stage T4 esophageal cancer. RMJ, 50 (4), 867-870.


Turabian Style

Qurashi, Ahmad Atta, Muhammad Arshad Javid, Saeed Ahmad Buzdar, Attique Anwar Khan, and Muhammad Shazad Shifa. 2025. Dosimetric comparison of IMRT versus 3D-CRT for Stage T4 esophageal cancer. Rawal Medical Journal, 50 (4), 867-870.


Chicago Style

Qurashi, Ahmad Atta, Muhammad Arshad Javid, Saeed Ahmad Buzdar, Attique Anwar Khan, and Muhammad Shazad Shifa. "Dosimetric comparison of IMRT versus 3D-CRT for Stage T4 esophageal cancer." Rawal Medical Journal 50 (2025), 867-870.


MLA (The Modern Language Association) Style

Qurashi, Ahmad Atta, Muhammad Arshad Javid, Saeed Ahmad Buzdar, Attique Anwar Khan, and Muhammad Shazad Shifa. "Dosimetric comparison of IMRT versus 3D-CRT for Stage T4 esophageal cancer." Rawal Medical Journal 50.4 (2025), 867-870. Print.


APA (American Psychological Association) Style

Qurashi, A. A., Javid, . M. A., Buzdar, . S. A., Khan, . A. A. & Shifa, . M. S. (2025) Dosimetric comparison of IMRT versus 3D-CRT for Stage T4 esophageal cancer. Rawal Medical Journal, 50 (4), 867-870.


Author LoginReviewer LoginEditorial PoliciesConflict of Interest PolicyPlagiarism PolicyAdvertising Policy

About Rawal Medical Journal

Publication, subscription and Editorial office PMA House G/220-B Liaquat Road, Rawalpindi. Phone: 051-555-9812, Fax: 051-553-7088 Email: drnkhokhar@ya ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information